HIGHLIGHTS
- who: Yesim Eralp from the Affiliated Hospital of the Chinese Academy of Military Medical Sciences, China have published the Article: Application of mRNA Technology in Cancer Therapeutics, in the Journal: Vaccines 2022, 10, of /2022/
- what: All patients enrolled in this trial had previously received immune checkpoint inhibitors.
- future: Research is required to optimize RNA stabilization delivery platforms and improve clinical efficacy by interacting with the tumor microenvironment to induce a long-term antitumor response. In this review data on current mRNA-based vaccines are discussed in the context of available evidence from . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.